Welcome to EndoChoice – A global leader and best-in-class technology provider for specialists treating a wide range of gastrointestinal diseases. EndoChoice is committed to the GI endoscopy market offering a comprehensive portfolio of treatment options, including the primary technologies used today - tissue acquisition, anatomic pathology, hemostasis, luminal patency, foreign body removal, infection control and procedural support.

With a legacy in technology development and innovation, EndoChoice is helping GI specialists around the world perform more effectively, predictably and in compliance to guidelines.  Since our founding in 2007, EndoChoice has been dedicated to developing innovative and clinically proven technologies and solutions for the diagnosis and treatment of gastrointestinal diseases, a strategy that we believe is uncommon in the medical device industry.

Our broad product portfolio is focused on applications that we estimate represent a worldwide gastroenterology market opportunity of approximately $5.4 billion in 2010. We sell our products in more than 26 countries through a direct sales force in the United States and through distributors in selected international markets. Our customers include a broad cross-section of physicians, including gastroenterologists, hepatologists and colo-rectal surgeons.